Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [41] Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
    Kim, Seok Jin
    Jo, Jae-Cheol
    Yoon, Dok Hyun
    Yang, Deok-Hwan
    Yoon, Sang Eun
    Lee, Gyeong-Won
    Kong, Jee Hyun
    Park, Yong
    Kang, Ka-Won
    Lee, Ho-Sup
    Oh, Sung Yong
    Shin, Ho-Jin
    Lee, Won Sik
    Choi, Yoon Seok
    Jeong, Seong Hyun
    Kim, Min Kyoung
    Kang, Hye Jin
    Yi, Jun Ho
    Lim, Sung-Nam
    Yhim, Ho-Young
    Do, Young Rok
    Yun, Hwan Jung
    Eom, Hyeon-Seok
    Lee, Mark Hong
    Suh, Cheolwon
    Kim, Won Seog
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Comparative Effectiveness and Cost of Adding Rituximab to First-Line Chemotherapy for Elderly Patients Diagnosed With Diffuse Large B-Cell Lymphoma
    Griffiths, Robert I.
    Gleeson, Michelle L.
    Mikhael, Joseph
    Dreyling, Martin H.
    Danese, Mark D.
    CANCER, 2012, 118 (24) : 6079 - 6088
  • [43] Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
    Kasamon, Y. L.
    Jones, R. J.
    Brodsky, R. A.
    Fuchs, E. J.
    Matsui, W.
    Luznik, L.
    Powell, J. D.
    Blackford, A. L.
    Goodrich, A.
    Gocke, C. D.
    Abrams, R. A.
    Ambinder, R. F.
    Flinn, I. W.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1203 - 1210
  • [44] Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience
    Bourcier, J.
    Gastinne, T.
    Leux, C.
    Moreau, A.
    Bossard, C.
    Mahe, B.
    Blin, N.
    Dubruille, V.
    Touzeau, C.
    Voldoire, M.
    Guillaume, T.
    Peterlin, P.
    Gallas, P.
    Garnier, A.
    Maisonneuve, H.
    Moreau, P.
    Juge-Morineau, N.
    Jardel, H.
    Chevallier, P.
    Moreau, P.
    Le Gouill, S.
    ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1287 - 1293
  • [45] Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission
    Chakhachiro, Zaher I.
    Saliba, Rima M.
    Okoroji, Grace-Julia
    Korbling, Martin
    Alousi, Amin M.
    Betul, Oran
    Anderlini, Paolo
    Ciurea, Stefan O.
    Popat, Uday
    Champlin, Richard
    Samuels, Barry I.
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Khouri, Issa F.
    CANCER, 2013, 119 (18) : 3318 - 3325
  • [46] Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network
    Kenkre, Vaishalee P.
    Long, Walter L.
    Eickhoff, Jens C.
    Blank, Jules H.
    McFarland, Thomas A.
    Bottner, Wayne
    Rezazedeh, Hamied
    Werndli, Jae E.
    Bailey, Howard H.
    Kahl, Brad S.
    LEUKEMIA & LYMPHOMA, 2011, 52 (09) : 1675 - 1680
  • [47] Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review
    Monga, Neerav
    Tam, Constantine
    Garside, Jamie
    Davids, Matthew S.
    Ward, Katherine
    Quigley, Joan
    Parisi, Lori
    Tapprich, Christoph
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 158
  • [48] Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
    Ekberg, Sara
    Smedby, Karin E.
    Albertsson-Lindblad, Alexandra
    Jerkeman, Mats
    Weibull, Caroline E.
    Glimelius, Ingrid
    BLOOD ADVANCES, 2023, 7 (05) : 866 - 874
  • [49] Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC
    Touzeau, Cyrille
    Leux, Christophe
    Bouabdallah, Reda
    Roussel, Murielle
    Delarue, Richard
    Bouabdallah, Krimo
    Thieblemont, Catherine
    Cacheux, Victoria
    Cartron, Guillaume
    Compain, Laetitia
    Gyan, Emmanuel
    Morschhauser, Franck
    Casasnovas, Olivier
    Moles, Marie-Pierre
    Michallet, Anne-Sophie
    Gressin, Remy
    Damaj, Gandhi
    Rose, Christian
    Sirvent, Anne
    Hermine, Olivier
    Mohty, Mohamad
    Milpied, Noel
    Le Gouill, Steven
    ANNALS OF HEMATOLOGY, 2014, 93 (02) : 233 - 242
  • [50] The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma
    Sawalha, Yazeed
    Radivoyevitch, Tomas
    Jia, Xuefei
    Tullio, Katherine
    Dean, Robert M.
    Pohlman, Brad
    Hill, Brian T.
    Kalaycio, Matt
    Majhail, Navneet S.
    Jagadeesh, Deepa
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 335 - 343
12345